NLM Digital Collections

Search

Start Over Subjects Fraud ✖Remove constraint Subjects: Fraud Subjects United States ✖Remove constraint Subjects: United States Copyright Public domain ✖Remove constraint Copyright: Public domain

1. Questionable billing for compounded topical drugs in Medicare Part D

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2018
Subject(s):
Dermatologic Agents -- economics
Dermatologic Agents -- therapeutic use
Drug Compounding -- economics
Drug Utilization -- trends
Fraud
Insurance, Health, Reimbursement
Medicare Part D -- economics
Skin Cream -- economics
Administration, Topical
Dermatologic Agents -- adverse effects
Drug Compounding -- standards
Forecasting
Health Expenditures -- trends
Insurance Coverage
Skin Cream -- adverse effects
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

4. State health- insurance marketplaces: three states used varied data sources for eligibility and had few indications of potentially improper enrollments : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, September 2017
Subject(s):
Cost Sharing -- economics
Eligibility Determination
Health Insurance Exchanges
Insurance, Health -- economics
Fraud
Income Tax
Humans
Idaho
Maryland
Rhode Island
United States
United States.
Centers for Medicare & Medicaid Services (U.S.)

7. Wholesale distributor verification requirement for saleable returned drug product and dispenser verification requirements when investigating a suspect or illegitimate product: compliance policies : guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):
Counterfeit Drugs
Drug Industry
Drug and Narcotic Control
Fraud
Government Regulation
Substandard Drugs
United States
United States.